Navigation Links
BUSM researchers find no adjustment method fully resolves confounding by indication
Date:5/26/2009

(Boston) - Researchers at Boston University School of Medicine (BUSM) and Boston University School of Public Health have found that no adjustment method fully resolves confounding by indication in observational studies, meaning when the validity of a study is threatened by unmeasured confounding, it is not straightforward to determine which method of adjustment, if any, is most effective in obtaining a valid and precise estimate of effect. The study appears online in the Journal of Clinical Epidemiology.

According to researchers, conventional methods to adjust for confounding, such as restriction and multivariable regression, leave residual confounding because of unmeasured factors. Propensity scores (PS) and instrumental variable (IV) methods have become increasingly popular with the intent to address residual confounding by simulating a randomized environment.

Using data from the Breast Cancer Effectiveness in Older Women study, a collaboration of investigators from the National Cancer Institute-funded Cancer Research Network, the researchers compared methods used to reduce confounding to estimate incidence rates of breast cancer recurrence in older women who received adjuvant chemotherapy compared with women who did not.

The researchers examined women 65 years of age or older diagnosed with early stage breast cancer. For women classified as high risk for recurrence, 20 percent experienced a breast cancer recurrence. In the unrestricted cohort, receipt of adjuvant chemotherapy was associated with recurrence. The PS distributions among women who received chemotherapy among those who did not showed no substantial overlap. Using the IV method, recurrence yielded a protective estimate. However, imbalances of measured factors across levels of the IV suggested residual confounding.

"With minimal trial-based information available to inform clinical guidelines, which currently offer no guidance for treating older women with cancer, non-randomized studies are vitally important," said lead author Jaclyn Bosco, MPH, project director in the Section of Geriatrics at BUSM. "Non-randomized studies are only reliable when confounding by indication is handled adequately. When treatment with adjuvant chemotherapy among older patients is based on clinical judgment, controlling for prognostic factors alone leaves residual confounding by indication."

Researchers further stated that PS and IV analysis methods can be useful under specific situations, but neither method adequately controlled confounding by indication in this study.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers gain ground in efforts to fight parasite infection
2. Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find
3. NYU School of Medicine pathology researchers solve another mystery in B lymphocyte development
4. Mayo Clinic Researchers Examine the Psychological Impact of Child Abuse
5. Mayo Clinic researchers examine the psychological impact of child abuse
6. CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime
7. Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
8. Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say
9. Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes
10. Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
11. BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow ... Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, ... College of Medicine. He also serves as Medical Director for the Bureau of Emergency ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare Solutions ... (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , BYOD ... devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. “BYOD ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Research and Markets has announced the ... Prospects: Addressing Production Complexities Through Risk Management and Quality ... ... and Market Prospects: Overcoming Production Complexities Through Risk Management ... the current trends in the global biosimilars market, with ...
(Date:4/20/2017)...  CVS Pharmacy, the retail division of CVS ... design to enhance the retail customer experience with ... and expanded beauty selections paired with informational signage ... offerings. Together with its innovative digital programs, these ... experience at CVS Pharmacy.  "Pharmacy ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
Breaking Medicine Technology: